medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2023, Number 6

<< Back

Salud Mental 2023; 46 (6)

Impact of menstrual cycle on smoking cessation: A review

Núñez-Lauriano M, Lira-Mandujano J, Míguez MC, Tiburcio M

Language: English
References: 32
Page: 325-331
PDF size: 238.67 Kb.


ABSTRACT

Background. Information on the way menstrual cycle phases can influence the achievement of tobacco abstinence is contradictory. Objective. A scope review was conducted to determine the effect of the menstrual cycle on tobacco abstinence, considering the phases of the cycle, hormone levels, and premenstrual syndrome. Method. A literature search was conducted in Scopus, PubMed, MEDLINE, and PsycINFO databases. Ten articles comparing the phases of the menstrual cycle or analyzing the association between premenstrual syndrome and a withdrawal condition (length of abstinence or withdrawal symptoms) were included. Results. Two main results were identified: 1) there is no difference in withdrawal symptoms and craving between menstrual cycle phases and 2) abstinence rates in the studies were higher during the luteal phase. Discussion and conclusion. The advisability of suggesting that women wishing to quit smoking should begin to do so at the start of the luteal phrase is discussed. However, smoking cessation interventions must consider all the symptoms experienced during the luteal phase.


REFERENCES

  1. al’Absi, M., Hatsukami, D., & Davis, G. L. (2005). Attenuated adrenocorticotropicresponses to psychological stress are associated with early smoking relapse.Psychopharmacology, 181(1), 107-117. doi: 10.1007/s00213-005-2225-3

  2. Allen, A. M., Allen, S. S., Lunos, S., & Pomerleau, C. S. (2010). Severity ofwithdrawal symptomatology in follicular versus luteal quitters: The combinedeffects of menstrual phase and withdrawal on smoking cessation outcome.Addictive Behaviors, 35(6), 549-552. doi: 10.1016/j.addbeh.2010.01.003

  3. Allen, A. M., Lunos, S., Heishman, S. J., al’Absi, M., Hatsukami, D., & Allen, S.S. (2015). Subjective response to nicotine by menstrual phase. AddictiveBehaviors, 43, 50-53. doi: 10.1016/j.addbeh.2014.12.008

  4. Allen, A. M., McRae-Clark, A. L., Carlson, S., Saladin, M. E., Gray, K. M.,Wetherington, C. L., … Allen, S. S. (2016). Determining menstrual phase inhuman biobehavioral research: A review with recommendations. Experimentaland Clinical Psychopharmacology, 24(1), 1-11. doi: 10.1037/pha0000057

  5. Allen, A., Skobic, I., Bell, M. L., Medvescek, K., Allen, S., Collins, B., & Nair, U.(2022). Feasibility and acceptability of testing a menstrual-cycle timed smokingcessation intervention for women of reproductive age (Project Phase): Resultsof a pilot randomized control trial. Addictive Behaviors, 125, 107153. doi:10.1016/j.addbeh.2021.107153

  6. Allen, S. S., Allen, A. M., Kotlyar, M., Lunos, S., al’Absi, M., & Hatsukami, D.(2013). Menstrual phase and depressive symptoms differences in physiologicalresponse to nicotine following acute smoking abstinence. Nicotine & TobaccoResearch, 15(6), 1091-1098. doi: 10.1093/ntr/nts236

  7. Allen, S. S., Allen, A. M., Tosun, N., Lunos, S., al’Absi, M., & Hatsukami, D. (2014).Smoking-and menstrual-related symptomatology during short-term smokingabstinence by menstrual phase and depressive symptoms. Addictive Behaviors,39(5), 901-906. doi: 10.1016/j.addbeh.2014.01.029

  8. Carlson, S. C., Allen, A. M., Allen, S. S., & al’Absi, M. (2017). Differences in moodand cortisol by menstrual phase during acute smoking abstinence: A withinsubjectcomparison. Experimental and Clinical Psychopharmacology, 25(5),338-345. doi: 10.1037/pha0000142

  9. Carpenter, M. J., Upadhyaya, H. P., LaRowe, S. D., Saladin, M. E., & Brady, K.T. (2006). Menstrual cycle phase effects on nicotine withdrawal and cigarettecraving: a review. Nicotine & Tobacco Research, 8(5), 627-638. doi:

  10. 10.1080/1462220060091079370

  11. Castaldelli-Maia, J. M., Nesoff, E. D., Lima, D. R., Sanchez, Z. M., & Martins,S. S. (2022). The first day of smoking abstinence is more challenging forwomen than men: A meta-analysis and meta-regression across 12 low-andmiddle-income countries. Addictive Behaviors, 128, 107234. doi: 10.1016/j.addbeh.2021.107234

  12. Castellani, V., Gonçalves, P. D., Castaldelli-Maia, J., & Malbergier, A. (2020).Investigating gender differences for effectiveness and side effects of vareniclineduring smoking cessation treatment. Revista da Associação Médica Brasileira,66(2), 146-152. doi: 10.1590/1806-9282.66.2.146

  13. Choi, S. H., & Hamidovic, A. (2020). Association between smoking and premenstrualsyndrome: A Meta-Analysis. Frontiers in Psychiatry, 11, 575526. doi: 10.3389/fpsyt.2020.575526

  14. Ditre, J. W., Zale, E. L., & Brandon, T. H. (2015). Patterns and predictors of smokingcessation. In The Tobacco Epidemic (2nd ed.). Karger Publishers.14. Farris, S. G., Abrantes, A. M., & Zvolensky, M. J. (2019). Emotional distress andtobacco demand during the menstrual cycle in female smokers. CognitiveBehaviour Therapy, 48(3), 177-183. doi: 10.1080/16506073.2018.1494208

  15. Franklin, T. R., & Allen, S. S. (2009). Influence of menstrual cycle phase onsmoking cessation treatment outcome: a hypothesis regarding the discordantfindings in the literature. Addiction, 104(11), 1941-1942. doi: 10.1111/j.1360-0443.2009.02758.x

  16. Hendricks, P. S., Wood, S. B., Baker, M. R., Delucchi, K. L., & Hall, S. M. (2011).The Smoking Abstinence Questionnaire: Measurement of smokers’ abstinencerelatedexpectancies. Addiction, 106(4), 716-728. doi: 10.1111/j.1360-0443.2010.03338.x

  17. Hughes, J. R. (2007). Effects of abstinence from tobacco: Valid symptomsand time course. Nicotine & Tobacco Research, 9(3), 315-327. doi:10.1080/14622200701188919

  18. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal.Archives of General Psychiatry, 43(3), 289-294. Retrieved from https://jamanetwork.com/journals/jamapsychiatry/article-abstract/493770

  19. Lynch, W., & Sofuoglu, M. (2010). Role of progesterone in nicotine addiction:Evidence from initiation to relapse. Experimental Clinical Psychopharmacol,18(6), 451-461. doi: 10.1037/a0021265

  20. McNulty, K. L., Elliott-Sale, K. J., Dolan, E., Swinton, P. A., Ansdell, P., Goodall,S., … Hicks, K. M. (2020). The effects of menstrual cycle phase on exerciseperformance in eumenorrheic women: a systematic review and meta-analysis.Sports Medicine, 50(10), 1813-1827. doi: 10.1007/s40279-020-01319-3

  21. Nakajima, M., Allen, S., & al’Absi, M. (2019). Influences of the menstrual phaseon cortisol response to stress in nicotine dependent women: A preliminaryexamination. Nicotine and Tobacco Research, 21(5), 617-622. doi: 10.1093/ntr/nty071

  22. Organización Mundial de la Salud. (2018). WHO global report on trends in prevalenceof tobacco smoking 2000-2025 (2nd ed.). World Health Organization. Retrievedfrom https://apps.who.int/iris/bitstream/handle/10665/272694/9789241514170-eng.pdf

  23. O’Dell, L. E., & Torres, O. V. (2014). A mechanistic hypothesis of the factors thatenhance vulnerability to nicotine use in females. Neuropharmacology, 76, 566-580. doi: 10.1016/j.neuropharm.2013.04.055

  24. Pang, R. D., Andrabi, N., & Leventhal, A. M. (2017). Premenstrual symptoms andfactors implicated in smoking cessation among woman smokers. Experimentaland Clinical Psychopharmacology, 25(4), 235-241. doi: 10.1037/pha0000132

  25. Pang, R. D., Bello, M. S., Stone, M. D., Kirkpatrick, M. G., Huh, J., Monterosso,J., … Leventhal, A. M. (2016). Premenstrual symptoms and smokingrelatedexpectancies. Addictive Behaviors, 57, 38-41. doi: 10.1016/j.addbeh.2016.01.015

  26. Perkins, K. A. (2001). Smoking cessation in women. Special considerations. CNSDrugs, 15(5), 391-411. doi: 10.2165/00023210-200115050-00005

  27. Schiller, C. E., Saladin, M. E., Gray, K. M., Hartwell, K. J., & Carpenter, M. J. (2012).Association between ovarian hormones and smoking behavior in women.Experimental and Clinical Psychopharmacology, 20(4), 251-257. doi: 10.1037/a0027759

  28. Sieminska, A., & Jassem, E. (2014). The many faces of tobacco use among women.Medical Science Monitor, 20, 153-162. doi: 10.12659/MSM.889796

  29. Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., ...Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR):checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. doi:10.7326/M18-0850

  30. Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke,J. P. (2008). Declaración de la iniciativa STROBE (Strengthening the Reportingof Observational studies in Epidemiology): directrices para la comunicación deestudios observacionales. Revista Española de Salud Pública, 82, 251-259. doi:10.1016/j.gaceta.2008.12.001

  31. Weinberger, A. H., Smith, P. H., Allen, S. S., Cosgrove, K. P., Saladin, M. E., Gray,K. M., Mazure, C. M., Wetherington, C. L., & McKee, S. A. (2015). Systematicand meta-analytic review of research examining the impact of menstrual cyclephase and ovarian hormones on smoking and cessation. Nicotine & TobaccoResearch, 17(4), 407-421. doi: 10.1093/ntr/ntu249

  32. Wetherill, R. R., Franklin, T. R., & Allen, S. S. (2016). Ovarian hormones, menstrualcycle phase, and smoking: a review with recommendations for future studies.Current Addiction Reports, 3(1), 1-8. doi: 10.1007/s40429-016-0093-z




2020     |     www.medigraphic.com